The NRG Oncology Podcast
door NRG Oncology
2026 Lung Cancer Awareness Month with Dr. Donington
Over deze podcast
The NRG Oncology Podcast, developed by NRG Oncology, is hosted by Drs. Stephen Chun and Lauren Henke. Stephen and Lauren delve into a variety of topics impacting the oncology community via interviews with various stakeholders throughout the NRG Oncology organization.
Afleveringen
De nieuwste 20 van 55 afleveringen
- 2026 Lung Cancer Awareness Month with Dr. Donington · 22 minFor 2026 Lung Cancer Awareness Month we discuss the evolution of lung cancer treatments and the importance of prevention and screening with Dr. Jessica Donington.
- NRG-BR002 Published in JCO · 14 minFor Breast Cancer Awareness Month, we discuss the results of the NRG-BR002 in newly oligometastatic breast cancer published in the Journal of Clinical Oncology today.
- NRG-HN009 p16-Negative Results at ASTRO 2026 · 14 minWe discuss the reported results of the NRG-HN009 p16-negative cohort presented at the ASTRO Annual Meeting Late-Breaking Abstract Session.
- NRG-CC009 and the MAVERICK Study at ASTRO 2026 · 22 minWe discuss both the NRG-CC009 study results presented during the 2026 ASTRO Annual Meeting Plenary Session and the MAVERICK study results presented during the Clinical Trials…
- NRG-GI003 Results in the ASTRO 2026 Plenary · 14 minWe discuss the NRG-GI003 results presented during the 2026 ASTRO Annual Meeting Plenary Session.
- The SPPORT Study Analysis Results at ASTRO 2026 · 12 minWe interview Dr. Shang "George" Zhao on the NRG-RTOG 0534 "SPPORT" study results he presented at the 2026 ASTRO Annual Meeting Clinical Trials Session.
- The NRG-GY036 Trial for Ovarian Cancer Month · 23 minFor the 2026 Ovarian Cancer Month & Gynecologic Cancer Month, we discuss the currently enrolling NRG-GY036 clinical trial comparing 1 vs. 2 years of maintenance olaparib (with or…
- NRG-HN016: The "CONCISE" Study for Locoregionally Advanced Head and Neck Cancer Patients that are Unable to Take Cisplatin · 17 minOur co-hosts interview the PI of the active NRG-HN016 (CONCISE) trial, Dr. Loren Mell. The CONCISE study is a randomized phase III trial comparing radiation therapy (RT) plus…
- NRG-GU015, the "ARCHER" Study for Muscle Invasive Bladder Cancer · 28 minOur co-hosts welcome Dr. Scott Delacroix and Dr. Himanshu Nagar to discuss bladder cancer, bladder preservation, and the newly activated NRG-GU015 (ARCHER) clinical trial. In…
- NRG2026 and Glioblastoma Awareness Day Special · 39 minFor Glioblastoma Awareness Day we discuss the NRG-CC017 study of TMPRT + Temozolomide for glioblastoma with PI, Dr. Huang. We also discuss the challenges faced by larger…
- Uterine Cancer Awareness Month 2026 · 50 minThis special Uterine Cancer Month episode includes three different perspectives in Uterine Cancer research. First we interview uterine and ovarian cancer survivor, NRG PAC…
- Prostate Cancer Analysis and Translational Science from ASCO 2026 · 30 minIn this episode, we discuss the results of the combined analysis of the prostate cancer studies RTOG 9202, 9413, 9902, and 0521 as well as learn more about translational science…
- NRG-GY018 Mature Results from ASCO 2026 · 18 minOur Podcast Co-Hosts interview NRG-GY018 study PI, Dr. Ramez Eskander on the reported mature results of the study in advanced or recurrent endometrial cancer at ASCO 2026.
- Special Episode with ASTRO’s CEO for ASTRO Advocacy Day · 31 minThe NRG Oncology Podcast discusses the American Society for Radiation Oncology’s (ASTRO) vision and goals, collaborations with cooperative groups such as NRG Oncology, and…
- NRG-GY019 Plenary Presentation at SGO 2026 · 17 minOur co-hosts interview Dr. Amanda Nickles Fader on the recently present results of NRG-GY019.
- NRG-BR009 and the Importance of Cancer Screening · 51 minOur co-hosts discuss the NRG-BR009 'OFSET' study for premenopausal ER-positive/HER2-negative breast cancer patients that have a high risk of cancer returning with study team…
- Health Policy, Access, and Patient-Reported Outcomes · 37 minAmerican Medical Association President, Dr. Bobby Mukkamala, discusses how his personal experiences in his cancer journey impact his outlook and goals in his AMA Presidency & Dr…
- NRG-HN009 Reported at the MHNCS 2026 and NRG-HN010 · 38 minOur co-hosts interview NRG-HN009 PI Dr. Paul Harari on the recently reported initial results of NRG-HN009 at the 2026 Multidisciplary Head and Neck Cancer Symposium…
- NRG Protocol Operations Management Committee · 22 minOur co-hosts discuss who the NRG Protocol Operations Management "POM" Committee is and what they are responsible for with outgoing Chair, Dr. Maria Werner-Wasik and incoming…
- Sarcoma in NRG and Through the CT3 Foundation with Special Guests · 34 minIn the first half of this episode, our co-hosts interview NRG Oncology Sarcoma Subcommittee Chairs, Dr. Dian Wang and Dr. William Tseng on the priorities and goals of the newer…








